Influenza Vaccination Coverage Among Pregnant Women — United States, 2012–13 Influenza Season

Pregnant women and infants aged <6 months are at increased risk for influenza-related severe illness and hospitalization. Influenza vaccination of pregnant women has been shown to reduce the risk for illness in both mother and infant (1). To help protect pregnant women, the Advisory Committee on Immunization Practices (ACIP) and the American College of Obstetricians and Gynecologists recommend influenza vaccination for all women who are or will be pregnant during the influenza season, regardless of trimester (1,2). To estimate influenza vaccination coverage among pregnant women during the 2012–13 influenza season, CDC analyzed data from an Internet panel survey conducted April 1–12, 2013. Among 1,702 self-selected survey respondents pregnant at any time during the 4-month period of October 2012–January 2013, 50.5% reported they received influenza vaccination before or during their pregnancy. Influenza vaccination coverage was higher among women reporting both a health-care provider recommendation and offer of influenza vaccination (70.5%) compared with women who received a recommendation but no offer of vaccination (46.3%) and women who received no recommendation (16.1%). Vaccination coverage of women who will be or are pregnant during an influenza season might be improved by implementing a combination of community-based interventions, including enhanced access to low-cost vaccination services, provider recommendation and offer of influenza vaccination, and education of pregnant women about influenza vaccination safety and efficacy during pregnancy to increase demand (3).

To provide end-of-season estimates of influenza vaccination coverage, health-care provider recommendation and offer of vaccination, and information on knowledge, attitudes, and behaviors related to influenza vaccination among women pregnant during the 2012–13 influenza season, before the 2013–14 influenza season, CDC conducted an Internet panel survey during April 1–12, 2013.* Women aged 18–49 years who were pregnant at any time since August 2012 were recruited from a SurveySpot panel, a general population opt-in Internet panel operated by Survey Sampling International.† Of 6,633 women who entered the survey, 2,198 were determined to be eligible, and 2,047 (93.1%) completed the survey.§ Data were weighted to reflect the age groups, race/ethnicity, and geographic distribution of the total U.S. population of pregnant women during 1990–2008.¶ The methods and questions used in the April 2013 survey were similar to the April 2011 and April 2012 surveys (4,5). However, for this analysis, vaccination status was defined differently from the analyses of the 2010–11 and 2011–12 influenza seasons: 1) the vaccination time frame changed to July through April, compared with the previous timeframe of August through April; and 2) a woman was considered vaccinated only if she was vaccinated before or during pregnancy, whereas previously women vaccinated after pregnancy had also been counted (4,5). In this analysis, the study population was limited to women reporting being pregnant any time during the usual peak influenza vaccination period of October–January (n = 1,702).

Survey respondents were asked questions about 1) their vaccination status before and during pregnancy, 2) whether their health-care provider recommended and offered influenza vaccination, 3) their attitudes regarding influenza and influenza vaccination, and 4) their reasons for receiving or not receiving influenza vaccination. To simplify the analysis, responses to five individual questions on attitudes were used to develop two composite scores defining attitudes toward influenza vaccination efficacy and the safety of influenza vaccination. A response to a sixth question was used as a measure of concern about influenza infection.** Because the study sample was based on pregnant women from an opt-in Internet panel rather than a probability sample, no statistical tests were performed. Differences were noted when there was a difference of ≥5 percentage points between any values being compared.

Of the 1,702 women pregnant at any time during October 2012–January 2013, 50.5% reported influenza vaccination since July 1, 2012; 14.6% were vaccinated before pregnancy and 35.9% during pregnancy (15.7% first trimester, 10.6% second trimester, 8.1% third trimester, and 1.5% unknown trimester) (Table 1). Among the 1,620 women with at least one health-care provider visit since July 2012 who provided information on a provider recommendation and offer, 54.6% reported receiving a provider recommendation and offer of vaccination, 16.7% reported receiving a provider recommendation but no offer of vaccination, and 28.7% reported receiving no recommendation. Women who reported receiving both a provider recommendation and offer of influenza vaccination had higher vaccination coverage (70.5%) compared with women who reported receiving a provider recommendation but no offer (46.3%) and women who reported receiving no recommendation (16.1%) (Table 1, Figure). Women with the following reported characteristics had lower influenza vaccination coverage than other women within each comparison stratum: aged 18–24 years, non-Hispanic black, having an education less than a college degree, not married, reporting no health insurance, not working for wages, living below the poverty level, having no high-risk conditions associated with increased complications for influenza, and having fewer than six health-care provider visits since July 2012 (Table 1). Vaccination coverage among women with a negative attitude toward the efficacy of influenza vaccination was 9.8%, compared with 64.2% among those with a positive attitude. Women with a negative attitude towards the safety of vaccination had lower coverage than those with a positive attitude (13.0% versus 65.6%), and those with no concern about influenza infection had lower coverage than those with concern about influenza infection (47.1% versus 52.8%) (Table 1). The outcomes regarding attitudes were similar whether using responses to the composite scores or the individual questions.

Overall, 72.3% of women reported receiving a health-care provider recommendation for vaccination, with or without reporting an offer of vaccination (Table 2). Women with both a provider recommendation and offer of influenza vaccination had higher vaccination coverage compared with women who received only a recommendation or who received no recommendation across all socio-demographic subgroups and attitude categories (Table 2). Among women who received a provider recommendation and offer of vaccination, coverage was 19.4% for those who reported a negative attitude toward influenza vaccination efficacy, 19.4% for those who reported a negative attitude towards the safety of influenza vaccination, and 68.8% for those who reported no concern about influenza infection; vaccination coverage was lower among women who did not receive a provider recommendation and also reported a negative attitude toward vaccination efficacy (2.5%) or the safety of influenza vaccination (7.7%) or no concern about influenza infection (15.6%).

The top three reasons women reported for vaccination were to protect their infant from influenza (33.2%), to protect themselves from influenza (20.0%), and because their health-care provider recommended vaccination (15.7%). The top three reasons reported for nonvaccination were concern about safety risk to the infant (20.5%), that the vaccination would give pregnant women influenza (13.6%), and that vaccination was not effective in preventing influenza (10.6%).

Reported by

Sarah Ball, ScD, Sara Donahue, DrPH, David Izrael, MS, Deborah K. Walker, EdD, Abt Associates, Inc., Cambridge, Massachusetts. Rachel Martonik, Charles DiSogra, DrPH, Abt SRBI, New York, New York. Helen Ding, MD, Stacie M. Greby, DVM, Katherine Kahn, MPH, Peng-Jun Lu, MD, PhD, Walter W. Williams, MD, James A. Singleton, PhD, Erin D. Kennedy, DVM, Carolyn B. Bridges, MD, Immunization Svcs Div, Lisa A. Grohskopf, MD, Influenza Div, National Center for Immunization and Respiratory Diseases; Denise J. Jamieson, MD, Indu Ahluwalia PhD, Div of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, CDC. Corresponding contributor: Helen Ding, hding@cdc.gov, 404-639-8513.

Editorial Note

Overall influenza vaccination coverage among pregnant women during the 2012–13 influenza season was 50.5%. Vaccination coverage among pregnant women was 47.0%–49.0% for the 2010–11 and 2011–12 influenza seasons (4,5); however, these estimates are not directly comparable because the change in the definition of vaccination status for this most recent season (including changing the measurement of influenza vaccination for pregnant women to July through April and restricting vaccination to receipt before or during pregnancy). Women reporting no health insurance, not working for wages, having fewer than six health-care provider visits since July 2012, or lower socioeconomic status indicators (less education and living below the poverty level) had lower vaccination coverage than other women in the survey. Negative attitudes toward the efficacy or safety of influenza vaccination and having no concern about influenza infection were also associated with lower vaccination coverage. Provider recommendation and offer of influenza vaccination was associated with higher levels of vaccination coverage, even when women reported no health insurance, not working for wages, lower socioeconomic status indicators, a negative attitude toward the efficacy or safety of influenza vaccination, or a lack of concern about influenza infection.

Among women with at least one health-care provider visit, 54.6% reported receiving a provider recommendation and offer of vaccination. In any practice, barriers to providers recommending and offering vaccination might include physician's concern about time spent discussing the vaccination; administrative and financial issues, such as concern about the up-front cost of ordering vaccines; high costs of storing and maintaining vaccines; not having electronic health records; and organizational challenges of vaccine administration (6–8). Systems supporting provider recommendation and offer, such as standing orders and provider reminder systems, can reduce missed opportunities for vaccination and improve vaccination coverage when implemented with strategies to improve access to vaccination services, such as strategies that reduce patient cost and increase demand (e.g., patient education) (3). Full implementation of the Affordable Care Act might allow access to ACIP-recommended vaccinations, such as influenza vaccination, for pregnant women with no cost sharing when provided by an in-network provider, and thus minimize concerns about vaccination cost. Providers who do not provide vaccinations in their office can recommend vaccination and refer pregnant women to another in-network provider that administers influenza vaccinations.

Pregnant women who were not vaccinated reported concern about the safety risk to their infants and the misconceptions that the vaccination would give them influenza or that vaccination was ineffective as the top reasons for nonvaccination. However, health-care provider recommendation and offer was associated with increased vaccination coverage in all demographic groups. Education messages for pregnant women need to emphasize that vaccination during pregnancy can protect not only pregnant women themselves but also their infants during the first 6 months of life (9). Such messages can be delivered through multiple means, including routine provider education, prenatal consultation, social media, and text messaging (e.g., https://text4baby.org). These efforts might help providers address negative attitudes and misconceptions about vaccination.

The findings in this report are subject to at least five limitations. First, estimates might be biased if the selection processes for entry into the Internet panel and a woman's decision to participate in this particular survey were related to receipt of vaccination. Comparing 2010–11 influenza season vaccination estimates from 18 states in both the Internet panel survey and the Pregnancy Risk Assessment Monitoring System (PRAMS), a probability sampling survey, the Internet panel survey estimate for women pregnant at any time during October 2010–January 2011 (50.2%) was similar to the estimate from PRAMS for women who were pregnant in the same period (49.2%) (10). Additional comparisons with PRAMS and other available data sources over multiple seasons are needed to determine whether the more timely Internet panel survey estimates, despite sampling differences, provide valid assessments of trends. Second, the survey was self-administered and not validated by medical record review. Third, the results were weighted to the distribution of pregnant women in the U.S. population, but the study sample did not include women without Internet access. Therefore, it might not be a representative sample of pregnant women, and findings might not be generalizable to all pregnant women in the United States. Fourth, this was a cross-sectional survey. Self-reported vaccination status, attitudes, and provider recommendation and offer were measured at the time of the survey. Interactions that happened before the survey (e.g., choosing a provider with similar attitudes or a change in attitudes because of a provider recommendation or offer) could not be captured by this survey. Finally, the 2012–13 influenza season coverage estimates are not directly comparable with estimates from the 2011–12 and 2010–11 seasons reported previously (4,5) because of the change in measuring vaccination coverage in this season.

Health-care provider recommendation and offer of influenza vaccination were associated with higher vaccination levels among pregnant women. Vaccination programs that include reducing patient cost of vaccination, reducing missed opportunities for vaccination by ensuring vaccination recommendations are provided at each visit, and increasing demand are needed (3). Tailored educational messages should emphasize that vaccination during pregnancy will not only decrease the risk for influenza-related illness and complications in pregnant women themselves, but can also decrease the risk for illness in infants for up to 6 months, while they are too young to be vaccinated (9).

Acknowledgments

Faith Lewis, MA, John Sokolowski, MA, Daniel Duplantier, MA, Abt SRBI, New York, New York. Megan C. Lindley, MPH, Immunization Svcs Div, National Center for Immunization and Respiratory Diseases; David P. Hopkins, MD, Div of Epidemiology, Analysis, and Library Svcs (proposed), Center for Surveillance, Epidemiology and Laboratory Svcs (proposed), Office of Public Health Scientific Svcs, CDC.

References

1. CDC. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2013–2014. MMWR 2013;62(No. RR-7).
2. American Congress of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG committee opinion no. 468: influenza vaccination during pregnancy. Obstet Gynecol 2010;116:1006–7.
3. Community Preventive Services Task Force. In: Guide to Community Preventive Services. Increasing appropriate vaccination: community-based interventions implemented in combination (abbreviated). Atlanta, GA: Community Preventive Services Task Force; 2013. Available at http://www.thecommunityguide.org/vaccines/communityinterventions.html.
4. CDC. Influenza vaccination coverage among pregnant women—United States, 2010–11 influenza season. MMWR 2011;60:1078–82.
5. CDC. Influenza vaccination coverage among pregnant women—2011–12 influenza season, United States. MMWR 2012;61:758–63.
6. Johnson DR, Nichol KL, Lipczynski K. Barriers to adult immunization. Am J Med 2008;121(7B):S28–35.
7. American Medical Association. Report 4 of the Council on Science and Public Health (I-08). Financing of adult vaccines: recommendations for action. Chicago, Illinois: American Medical Association; 2008. Available at http://www.ama-assn.org/resources/doc/csaph/csaph4i08-summary.pdf.
8. Panda B, Stiller R, Panda A. Influenza vaccination during pregnancy and factors for lacking compliance with current CDC guidelines. J Matern Fetal Neonatal Med 2011;24:402–6.
9. Meharry PM, Colson ER, Grizas AP, Stiller R, Vázquez M. Reasons why women accept or reject the trivalent inactivated influenza vaccine (TIV) during pregnancy. Matern Child Health J 2013;17:156–64.
10. Ding H, Ahluwalia I, Euler G, Boyle J, Singleton J, Greby S. A comparison of a mailed-in probability sample survey and a non-probability Internet Panel Survey for assessing self-reported influenza vaccination levels among pregnant women. 68th annual conference of the American Association for Public Opinion Research; Boston, Massachusetts; May 16–19, 2013.